A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Psychomotor Effect of VI-0521 in Healthy Overweight and Obese Subjects.
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2013
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- Sponsors VIVUS
- 14 Nov 2009 Actual initiation date (Dec 2008), actual end date (May 2009) and actual number of patients (80) added as reported by ClinicalTrials.gov.
- 14 Nov 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2008 New trial record.